BridgeMD
New treatment option for High-risk Lung Resection Surgery
Official title Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery
ClinicalTrials.gov ID: NCT06156943
What this study is testing
- What it's testing
- High-risk patients scheduled for lung resection surgery are increasing and theoretically eligible to perioperative individualized goal-directed fluid therapy (GDFT). However, thoracic surgery is challenging for intraoperative stroke volume (SV) and/or cardiac output monitoring because it requires lateral positioning, one-lung ventilation, and open-chest condition.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults (≥ 18 years old)
- High-risk patients (ASA score ≥ 3 and/or ventilatory deficit (defined as FEV1≤70% and/or VC≤70%) and/or AKI risk index ≥ III and/or modified clinical...
- Patients who have provided written informed consent to participate in the study
- Patients affiliated with a social health insurance
You likely can't join if
- Pleural or mediastinal resection surgery
- Emergency surgery (Less than 24h)
- Patients unable to understand the purpose of the study
- Patients participating in another trial that would interfere with this study
- Female patients who are pregnant, lactating or women of child-bearing potential without effective methods of contraception
- Female patients with positive β-HCG blood test
See the full eligibility criteria
- Adults (≥ 18 years old)
- High-risk patients (ASA score ≥ 3 and/or ventilatory deficit (defined as FEV1≤70% and/or VC≤70%) and/or AKI risk index ≥ III and/or modified clinical Lee Criteria ≥2) undergoing elective open-chest or video-assisted or...
- Patients who have provided written informed consent to participate in the study
- Patients affiliated with a social health insurance
- Pleural or mediastinal resection surgery
- Emergency surgery (Less than 24h)
- Patients unable to understand the purpose of the study
- Patients participating in another trial that would interfere with this study
- Female patients who are pregnant, lactating or women of child-bearing potential without effective methods of contraception
- Female patients with positive β-HCG blood test
- Patients under judicial protection (guardianship, curatorship)
The study team makes the final eligibility decision.
Where it's taking place
- Bron, France
- Dijon, France
- Montpellier, France
- Nancy, France
- Paris, France
- Pessac, France
- Rennes, France
- Saint-Herblain, France
- Strasbourg, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, France; Dijon, France; Montpellier, France; Nancy, France; Paris, France; Pessac, France and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.